procaterol has been researched along with Muscle Relaxation in 16 studies
Procaterol: A long-acting beta-2-adrenergic receptor agonist.
Muscle Relaxation: That phase of a muscle twitch during which a muscle returns to a resting position.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Conversely, the IAS smooth muscle relaxation caused by beta(1)- and beta(2)-AR agonists (xamoterol and procaterol, respectively) was selectively antagonized by their respective antagonists CGP 20712 [(+/-)-2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenoxy]propyl]amino]ethoxy]-benzamide methanesulfonate salt] and ICI 118551." | 3.72 | Functional and molecular characterization of beta-adrenoceptors in the internal anal sphincter. ( Banwait, K; Kazerounian, S; Rathi, S; Rattan, S; Schulz, S; Waldman, SA, 2003) |
| "The purpose of the present study was to ascertain the role of adenylate (AC) versus guanylate cyclase (GC) signaling pathways in the internal anal sphincter (IAS) smooth muscle relaxation by beta(1)-, beta(2)-, and beta(3)-adrenoceptor (AR) activation by xamoterol, procaterol, and disodium 5-[(2R)-2-(3-chlorophenyl)-2-hydroxy-ethyl]amino)propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316243), respectively." | 3.72 | Role of adenylate and guanylate cyclases in beta1-, beta2-, and beta3-adrenoceptor-mediated relaxation of internal anal sphincter smooth muscle. ( De Godoy, M; Li, F; Rattan, S, 2004) |
| "We examined the effects of four beta 2-agonists, clenbuterol, metaproterenol, procaterol, and albuterol, on the contractility of fatigued canine diaphragm." | 3.68 | Effects of beta 2-agonists on the contractility of fatigued canine diaphragm in vivo. ( Miyashita, A; Numata, H; Okubo, T; Suzuki, M; Suzuki, S, 1993) |
| "Prazosin was 300 times more active than rauwolscine in inhibiting NA-induced contractions." | 1.27 | Comparison of the responses to drugs acting on adrenoreceptors and muscarinic receptors in human isolated corpus cavernosum and cavernous artery. ( Andersson, KE; Hedlund, H, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (25.00) | 18.7374 |
| 1990's | 6 (37.50) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rathi, S | 1 |
| Kazerounian, S | 1 |
| Banwait, K | 1 |
| Schulz, S | 1 |
| Waldman, SA | 1 |
| Rattan, S | 2 |
| Takeda, H | 3 |
| Matsuzawa, A | 1 |
| Igawa, Y | 3 |
| Yamazaki, Y | 3 |
| Kaidoh, K | 1 |
| Akahane, S | 1 |
| Kojima, M | 1 |
| Miyata, H | 1 |
| Akahane, M | 3 |
| Nishizawa, O | 3 |
| Li, F | 1 |
| De Godoy, M | 1 |
| Badawi, JK | 1 |
| Uecelehan, H | 1 |
| Hatzinger, M | 1 |
| Michel, MS | 1 |
| Haferkamp, A | 1 |
| Bross, S | 1 |
| Johansson, LH | 1 |
| Persson, H | 1 |
| Rosengren, E | 1 |
| Numata, H | 1 |
| Suzuki, S | 1 |
| Miyashita, A | 1 |
| Suzuki, M | 1 |
| Okubo, T | 1 |
| Ajisawa, Y | 2 |
| Yoneyama, T | 1 |
| Yono, M | 1 |
| Yoshida, M | 1 |
| Takahashi, W | 1 |
| Inadome, A | 1 |
| Seshita, H | 1 |
| Miyamoto, Y | 1 |
| Ueda, S | 1 |
| Small, RC | 1 |
| Chiu, P | 1 |
| Cook, SJ | 1 |
| Foster, RW | 1 |
| Isaac, L | 1 |
| Komatsu, Y | 1 |
| Kikkawa, H | 1 |
| Naito, K | 1 |
| Ikezawa, K | 1 |
| Doggrell, SA | 2 |
| Fujiwara, T | 1 |
| Sumimoto, K | 1 |
| Itoh, T | 1 |
| Suzuki, H | 1 |
| Kuriyama, H | 1 |
| Ikezono, K | 1 |
| Zerkowski, HR | 1 |
| Beckeringh, JJ | 1 |
| Michel, MC | 1 |
| Brodde, OE | 1 |
| Hedlund, H | 1 |
| Andersson, KE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Controlled,14-Treatment Day, Multicenter Study to Determine the Optimal Efficacious and Safe Dose of CHF 4226 in a Metered Dose Inhaler in Treating Patients With Chronic Obstructive Pulmonary Disease[NCT00605891] | Phase 2 | 278 participants (Actual) | Interventional | 2006-10-31 | Completed | ||
| Evaluation of the Effect of 2 Weeks Treatment With CHF 4226 pMDI 2µg and 4µg, Given Once Daily in the Morning, on 24-Hour FEV1 in Patients With COPD[NCT00640484] | Phase 2 | 57 participants (Actual) | Interventional | 2008-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
16 other studies available for procaterol and Muscle Relaxation
| Article | Year |
|---|---|
Functional and molecular characterization of beta-adrenoceptors in the internal anal sphincter.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Anal Canal; Animals; Blotting, Western; In Vi | 2003 |
Functional characterization of beta-adrenoceptor subtypes in the canine and rat lower urinary tract.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Dioxoles; Dobutamine; Dogs; Female; | 2003 |
Role of adenylate and guanylate cyclases in beta1-, beta2-, and beta3-adrenoceptor-mediated relaxation of internal anal sphincter smooth muscle.
Topics: Adenine; Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blotting | 2004 |
Relaxant effects of beta-adrenergic agonists on porcine and human detrusor muscle.
Topics: Adrenergic beta-Agonists; Aged; Albuterol; Animals; Dioxoles; Dose-Response Relationship, Drug; Epin | 2005 |
Is there any evidence of beta 1-adrenoceptors mediating relaxation of guinea-pig lung parenchyma?
Topics: Adrenergic beta-Antagonists; Animals; Ethanolamines; Guinea Pigs; In Vitro Techniques; Isoproterenol | 1984 |
Effects of beta 2-agonists on the contractility of fatigued canine diaphragm in vivo.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Blood Pressure; Clenbuterol; Diaphragm; Dogs; Dose-Res | 1993 |
Possible beta 3-adrenoceptor-mediated relaxation of the human detrusor.
Topics: Adrenergic Antagonists; Adrenergic beta-Agonists; Adult; Aged; Bupranolol; Dobutamine; Dose-Response | 1998 |
Effects of ovarian hormones on beta-adrenergic receptor-mediated relaxation in the female rabbit bladder.
Topics: Adrenergic beta-Agonists; Animals; Carbachol; Dobutamine; Estrogens; Female; Isoproterenol; Muscle R | 2000 |
Beta-adrenoceptor agonists in bronchial asthma: role of k+-channel opening in mediating their bronchodilator effects.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Anta | 1993 |
Characterization of beta-adrenoceptor subtypes in the ferret urinary bladder in vitro and in vivo.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Anesthesia; Animals; Blood Pressure; Dioxoles | 2000 |
Tracheal relaxing effects and beta 2-selectivity of TA-2005, a newly developed bronchodilating agent, in isolated guinea pig tissues.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Amphetamines; Animals; Bronchodila | 1991 |
Tracheal relaxing effects and beta 2-selectivity of TA-2005, a newly developed bronchodilating agent, in isolated guinea pig tissues.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Amphetamines; Animals; Bronchodila | 1991 |
Tracheal relaxing effects and beta 2-selectivity of TA-2005, a newly developed bronchodilating agent, in isolated guinea pig tissues.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Amphetamines; Animals; Bronchodila | 1991 |
Tracheal relaxing effects and beta 2-selectivity of TA-2005, a newly developed bronchodilating agent, in isolated guinea pig tissues.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Amphetamines; Animals; Bronchodila | 1991 |
The effects of (+/-)-, (+)- and (-)-celiprolol and bromoacetylalprenololmentane at the beta-adrenoceptors of rat isolated cardiovascular preparations.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Celiprolol; Electric Stimulation; Ethanolamines; H | 1990 |
Relaxant and beta 2-adrenoceptor blocking activities of (+/- )-, (+)- and (-)-pindolol on the rat isolated aorta.
Topics: Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Ethanolamines; In Vitro Techniques; Male; Mus | 1990 |
Relaxing actions of procaterol, a beta 2-adrenoceptor stimulant, on smooth muscle cells of the dog trachea.
Topics: Adrenergic beta-Agonists; Animals; Calcium; Cyclic AMP; Cytosol; Dogs; Drug Interactions; Ethanolami | 1988 |
Beta-2 adrenoceptor-mediated relaxation of the isolated human saphenous vein.
Topics: Bisoprolol; Ethanolamines; Female; Humans; In Vitro Techniques; Male; Mathematics; Muscle Relaxation | 1987 |
Comparison of the responses to drugs acting on adrenoreceptors and muscarinic receptors in human isolated corpus cavernosum and cavernous artery.
Topics: Acetylcholine; Aged; Carbachol; Clonidine; Electric Stimulation; Ethanolamines; Humans; In Vitro Tec | 1985 |